| Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Z Wang, EG Aguilar, JI Luna, C Dunai, LT Khuat, CT Le, A Mirsoian, ... Nature medicine 25 (1), 141-151, 2019 | 627 | 2019 |
| Surgery versus surveillance for well‐differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11‐year analysis of the national cancer database HA Assi, S Mukherjee, PL Kunz, M Machiorlatti, S Vesely, V Pareek, ... The oncologist 25 (2), e276-e283, 2020 | 64 | 2020 |
| Socioeconomic differences in nicotine exposure and dependence in adult daily smokers A Chen, M Machiorlatti, NM Krebs, JE Muscat BMC Public Health 19 (375), 2019 | 60 | 2019 |
| Interrater reliability of assessing levator ani deficiency with 360° 3D endovaginal ultrasound G Rostaminia, J Manonai, E Leclaire, F Omoumi, M Marchiorlatti, ... International urogynecology journal 25, 761-766, 2014 | 45 | 2014 |
| Incidence of vascular thromboembolic events in patients receiving immunotherapy: a single institution experience S Ibrahimi, M Machiorlatti, SK Vesely, M Malla, F Modhia, SA Jones, ... Blood 130, 4864, 2017 | 30 | 2017 |
| Personalized dosing versus fixed dosing of immune checkpoint inhibitors: a cost analysis study S Mukherjee, S Ibrahimi, M Machiorlatti, D Roman, R Saleem, A Hassan, ... American Journal of Therapeutics 25 (6), e767-e768, 2018 | 14 | 2018 |
| Predictors of outcome in patients with fibrolamellar carcinoma: analysis of the National Cancer Database HA Assi, S Mukherjee, M Machiorlatti, S Vesely, V Pareek, H Hatoum Anticancer Research 40 (2), 847-855, 2020 | 13 | 2020 |
| Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy HA Assi, AS Asch, M Machiorlatti, SK Vesely, S Ibrahimi Future Science OA 6 (7), FSO581, 2020 | 11 | 2020 |
| Outcomes and prognostic factors of resected salivary gland malignancies: Examining a single institution's 12-year experience T Gutschenritter, M Machiorlatti, S Vesely, B Ahmad, W Razaq, M Razaq Anticancer Research 37 (9), 5019-5025, 2017 | 11 | 2017 |
| Perceptions of Proper Ethical Conduct of Russia's Future Business Managers: A replication of Deshpande, Joseph, and Maximov M Ludlum, S Moskalionov, M Machiorlatti The Business Review, Cambridge 11 (1), 267-272, 2008 | 9 | 2008 |
| Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile A Ikeguchi, M Machiorlatti, SK Vesely Melanoma Management 7 (2), MMT43, 2020 | 7 | 2020 |
| Effect of body mass index and albumin level on outcomes of patients receiving anti PD-1/PD-L1 therapy. S Ibrahimi, S Mukherjee, D Roman, C King, M Machiorlatti, R Aljumaily Journal of Clinical Oncology 36 (5_suppl), 213-213, 2018 | 7 | 2018 |
| Gross tumour volume variations in primary non‐small‐cell lung cancer during the course of treatment with stereotactic body radiation therapy T Gunter, I Ali, C Matthiesen, M Machiorlatti, D Thompson, O Algan Journal of medical imaging and radiation oncology 58 (3), 384-391, 2014 | 7 | 2014 |
| Impact of health care insurance status on treatment outcomes of acute myeloid leukemia SA Srour, M Machiorlatti, NT Pierson, UZ Bhutta, M Cherry, GB Selby, ... Clinical Lymphoma Myeloma and Leukemia 17 (7), 450-456. e2, 2017 | 5 | 2017 |
| Discontinuation of antimicrobial prophylaxis (AP) in children with spina bifida: a case series analysis KG Couloures, M Anderson, M Machiorlatti, O Marsenic, L Opas Nephro-Urology Monthly 8 (5), 2016 | 5 | 2016 |
| Factors associated with meeting physical activity guidelines during the COVID-19 pandemic NI Heredia, M Machiorlatti, BM Reininger, C Robledo BMC public health 22 (1), 2178, 2022 | 4 | 2022 |
| Patterns of colorectal cancer in Texas counties from 2000 to 2017 M LaPelusa, F Diaz, M Machiorlatti JCO Oncology Practice 18 (5), e770-e779, 2022 | 4 | 2022 |
| Variability of the pubic arch architecture and its influence on the minimal levator hiatus area G Rostaminia, M Machiorlatti, SA Shobeiri, LH Quiroz International Journal of Gynecology & Obstetrics 134 (2), 217-220, 2016 | 4 | 2016 |
| „A Case Study on future Russian Business Managers‟ M Ludlum, M Machiorlatti, S Moskalionov Ethics and Critical Thinking Quarterly, 1-10, 2009 | 4 | 2009 |
| Factors contributing to SARS-CoV-2 vaccine hesitancy of Hispanic population in Rio Grande valley A Bikaki, M Machiorlatti, LC Clark, CA Robledo, IA Kakadiaris Vaccines 10 (8), 1282, 2022 | 3 | 2022 |
